Custom Derived Hepatocytes


Tempo-iHepTM are human iPS-derived hepatocytes.

If you would like to purchase them, please contact us to discuss your particular requirements. Please inquire for ready-to-ship Human iPS-derived Hepatocytes. 96-well format. Ethnically diverse lines available.


Custom Hepatocytes; anti-E-Cadherin ICC

More Views

  • Custom Hepatocytes
  • Custom Hepatocytes; anti-Albumin ICC
  • Custom Hepatocytes; anti-E-Cadherin ICC


Tempo-iHepTM are human iPS-derived hepatocytes.
One of the most widely used cell types in research, drug development, and toxicity testing is hepatocytes (liver cells). Existing liver models (for cell culture based systems) include primary human hepatocytes harvested from donors, immortalized cell lines (such as HepG2), and cells from rodent models. Each of these models suffers experimental limitations. For example, studies have shown that variabilities in hepatocyte functions are observed depending on genotype and environmental background of each donor. Immortalized cell lines are ubiquitously used in research, but they suffer a variety of functional deficiencies that are critical for evaluating metabolism and toxicity of drug candidates. Hence, iPS-derived hepatocytes are developed to overcome deficiencies found in traditional methods and systems.

Please inquire for ready-to-ship Human iPS-derived Hepatocytes. 96-well format. Ethnically diverse lines available.


  • Disease modeling (e.g., metabolic disorders, urological disorders, diabetes)
  • Liver toxicity testing for drug development
  • Phenotypic Assays (e.g., induction of lineage-specific marker proteins, cytotoxicity assays)
  • Research and development of cellular therapies in animal models
  • Studying liver differentiation
  • Identifying functional biomarkers
  • 3D Spheroid hepatic assays

Custom-Derivation of human iPS-derived Hepatocytes:

Characterizations performed: biomarker confirmation (E-Cadherin and albumin); calcium imaging (upon request); CYP metabolism assay (upon request);

Approximate turn-around time: ~14-16 weeks (from fibroblasts) and ~10 weeks (for iPSCs)

Sample requirements: human fibroblasts or iPSCs, ~5x10^5 cells. Please contact us, if you'd prefer to use blood samples

Technology used: an in-house developed proprietary feeder-free, serum-free, viral/genetic-elements-free, integration-free reprogramming method.

Deliverables: >2x10^6 cells (scale-up possible). BioSafety Level 2.


Additional Information

Product Use Custom hepatocytes are intended for basic scientific research drug discovery, and therapeutics development use only. It is not a product for human testing or diagnostics.